US 11225664
Modulation of angiopoietin-like 3 expression
granted A61PA61P1/16A61P3/00
Quick answer
US patent 11225664 (Modulation of angiopoietin-like 3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P3/04, A61P3/06